Last reviewed · How we verify

NCT03628950

Interscalene Versus Combined Infraclavicular-suprascapular Nerve Blocks

Completed NA Last updated 16 March 2022
What this trial tests

NA trial testing ICSSB group in Postoperative Pain in 66 participants. Completed in 30 September 2020.

Timeline
1 September 2018
Primary endpoint
31 August 2020
30 September 2020

Quick facts

Lead sponsorFayoum University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment66
Start date1 September 2018
Primary completion31 August 2020
Estimated completion30 September 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Fayoum University Hospital

Who can join

18 and older, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this trial is to compare the analgesic efficiency and hemi-diaphragmatic paralysis of the standard ultrasound-guided interscalene (ISB) brachial plexus block with the combined use of costoclavicular approach of infraclavicular brachial plexus block and suprascapular nerve block (ICB-SSB) for patients undergoing arthroscopic rotator cuff repair. Authors hypothesize that the combined use of ICB-SSB could lead to equivalent postoperative analgesic effect to the standard ISB with less hemi-diaphragmatic paralysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Fayoum University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03628950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing